Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Myeloproliferative neoplasms: from origins to outcomes
HTML
PDF
Details
Locations
Year:
2017
Type:
review
Source:
Blood
DOI:
10.1182/blood-2017-06-782037
Authors:
Jyoti Nangalia,
Anthony R. Green
Institutions:
Wellcome Sanger Institute,
Wellcome/MRC Cambridge Stem Cell Institute,
University of Cambridge,
Addenbrooke's Hospital,
Wellcome Trust
Language:
English
Topic:
Myeloproliferative Neoplasms: Diagnosis and Treatment
Subfield:
Hematology
Field:
Medicine
Domain:
Health Sciences
Keywords:
myeloproliferative neoplasms,
JAK inhibitors,
CALR mutation,
somatic mutations,
clonal expansion,
myelofibrosis,
prognostic mutations,
genomic profiling,
disease biology,
clinical outcomes,
targeted therapy
show all 11
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Wellcome Trust,
Cancer Research UK,
National Institute for Health and Care Research,
Medical Research Council,
NIHR Cambridge Biomedical Research Centre
Awards:
Wellcome Trust MRC Cambridge Stem Cell Institute,
G34383514,
G4942724448
OpenAlex ID:
W2761473139
FWCI:
2.058
Cites:
110
Cited by:
188
Related to:
10